Frontiers in Allergy | Therapies and Therapeutic Targets

Original Research

Accepted on 06 Aug 2025

One-Year Real-Life Outcomes of Lanadelumab Therapy in Romanian Patients with Hereditary Angioedema Due to C1-inhibitor Deficiency

in Therapies and Therapeutic Targets

Noémi Anna Bara
Valentin Nadasan
Diana Deleanu

Frontiers in Allergy

doi 10.3389/falgy.2025.1636425

149 views

Review

Published on 01 Aug 2025

Advancing equity in allergy and immunology: progress, pitfalls, and the path forward

in Therapies and Therapeutic Targets

Philip Mendez
Ayobami Akenroye
Sharmilee M. Nyenhuis
Juan Carlos Cardet

Frontiers in Allergy

doi 10.3389/falgy.2025.1639718

725 views

Correction

Published on 14 Jul 2025

Correction: Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation

in Therapies and Therapeutic Targets

Chunyan Wang
Haiying Liu
Xiaoli Li
Wei Kong
Hui Wu
Congfu Huang

Frontiers in Allergy

doi 10.3389/falgy.2025.1655751

718 views

Case Report

Published on 02 Jul 2025

Case reports of subcutaneous pdC1INH in pregnancy and lactation: expanding treatment options for hereditary angioedema in Portugal

in Therapies and Therapeutic Targets

Ana Luísa Pinhal
Natacha Santos
Eunice Dias de Castro

Frontiers in Allergy

doi 10.3389/falgy.2025.1604440

972 views

Original Research

Published on 23 May 2025

Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes

in Therapies and Therapeutic Targets

Jeremiah Hwee
Lynn Huynh
Wilson da Costa
Marc E. Rothenberg
Mei Sheng Duh
Rafael Alfonso-Cristancho

Frontiers in Allergy

doi 10.3389/falgy.2025.1605397

1,505 views

Original Research

Published on 13 May 2025

Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma

in Therapies and Therapeutic Targets

Abraham Alí-Munive
Josefina Zakzuk
Nelson J. Alvis-Zakzuk
Elizabeth García
Claudia Diaz Bossa
Diana Jimena Cano Rosales
Fabio Bolívar
Alejandro Carreño
Paula Rodríguez-Ordoñez
Natalia Gómez-Ardila

Frontiers in Allergy

doi 10.3389/falgy.2025.1564033

1,756 views

Original Research

Published on 09 May 2025

Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation

in Therapies and Therapeutic Targets

Chunyan Wang
Haiying Liu
Xiaoli Li
Wei Kong
Hui Wu
Congfu Huang

Frontiers in Allergy

doi 10.3389/falgy.2025.1562832

1,928 views

Clinical Trial

Published on 10 Apr 2025

A randomized controlled trial evaluating prophylactic treatment of Artemisia pollinosis using azelastine hydrochloride and fluticasone propionate nasal spray

in Therapies and Therapeutic Targets

Le Cui
Na Gao
Cairong Bai
Yali Zuo
Wendong Hao
Kai Guan

Frontiers in Allergy

doi 10.3389/falgy.2025.1559201

1,470 views

Editorial

Published on 04 Apr 2025

Editorial: Allergies and anti-allergy drug discovery in Africa

in Therapies and Therapeutic Targets

Sabelo Hadebe
Andrew Glory Mtewa
Mushagalusa Kasali Félicien
Jonathan Peter
Precious Takondwa Makondi

Frontiers in Allergy

doi 10.3389/falgy.2025.1593023

801 views

Original Research

Published on 27 Feb 2025

Profiling of the gut, skin and nasal microbiotas revealed clinically relevant microbial taxa from children with allergies: a pilot study

in Therapies and Therapeutic Targets

Jiayi Hong
Zhiwei Tang
Dongjun Zhang
Chenqi Mo
Wen Su
Jie Shao

Frontiers in Allergy

doi 10.3389/falgy.2025.1497914

1,759 views

Correction

Published on 14 Feb 2025

Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema

in Therapies and Therapeutic Targets

Dan Sexton
Ryan Faucette
Melody Rivera-Hernandez
Jon A. Kenniston
Nikolaos Papaioannou
Janja Cosic
Kris Kopacz
Gary Salmon
Chantal Beauchemin
Salomé Juethner

Frontiers in Allergy

doi 10.3389/falgy.2025.1557356

977 views

Original Research

Published on 28 Nov 2024

Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting

in Therapies and Therapeutic Targets

S. P. P. Konyana
N. F. Teixeira
L. Pirjol
B. Thwala
W. Nkoyane
M. Porter
F. Gxolo
E. Phillips
R. Lehloenya
A. Mankahla

Frontiers in Allergy

doi 10.3389/falgy.2024.1481281

1,834 views

Original Research

Published on 02 Oct 2024

The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years

in Therapies and Therapeutic Targets

V. Schichter-Konfino
R. Mubariki
E. Toubi
Z. Vadasz

Frontiers in Allergy

doi 10.3389/falgy.2024.1464466

1,809 views

Original Research

Published on 25 Sep 2024

Correlation between forkhead box P3 (rs3761548) gene polymorphism and serum interleukin13 as biomarkers of severity in Egyptian allergic conjunctivitis: a retrospective study

in Therapies and Therapeutic Targets

Wesam A. Boghdady
Marwa A. Khairy
Ali G. Ali
Alia A. El Shahawy
Eman A. Abdelaziz
Aya A. El Shahawy
Fatma Z. Kamel

Frontiers in Allergy

doi 10.3389/falgy.2024.1437600

1,464 views
1 citation

Case Report

Published on 19 Sep 2024

The management of exercise-induced anaphylaxis in a Chinese child with biologics: a case report

in Therapies and Therapeutic Targets

Nannan Jiang
Li Xiang
Huijie Huang
Xudong Zhang

Frontiers in Allergy

doi 10.3389/falgy.2024.1453873

1,988 views

Original Research

Published on 17 Sep 2024

A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema

in Therapies and Therapeutic Targets

Dan Sexton
Ryan Faucette
Melody Rivera-Hernandez
Jon A. Kenniston
Nikolaos Papaioannou
Janja Cosic
Kris Kopacz
Gary Salmon
Chantal Beauchemin
Salomé Juethner

Frontiers in Allergy

doi 10.3389/falgy.2024.1436855

3,387 views
1 citation